Costanza Bogani

Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli et al. · Leukemia · 2007 · 361 citations

Medicine, Hematology, Molecular Medicine +5

Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia

Elisabetta Antonioli, Paola Guglielmelli, G Poli et al. · Haematologica · 2007 · 159 citations · Full text

Medicine, Hematology, Molecular Genetics +13

Co‐targeting the PI3K/ <scp>mTOR</scp> and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms

Niccolò Bartalucci, Lorenzo Tozzi, Costanza Bogani et al. · Journal of Cellular and Molecular Medicine · 2013 · 137 citations · Full text

Medicine, Oncology, Pharmacology +17

miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis

Ruggiero Norfo, Roberta Zini, Valentina Pennucci et al. · Blood · 2014 · 125 citations · Full text

Life Sciences, Cell Biology, Molecular Genetics +15

Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (<i>WT1</i>)

Paola Guglielmelli, Roberta Zini, Costanza Bogani et al. · Stem Cells · 2006 · 122 citations · Full text

Life Sciences, Cell Biology, Hematology +17